Tour Blog

Ridiculus sociosqu cursus neque cursus curae ante scelerisque vehicula.

The outlook for pharmaceutical cold chain logistics is expected to reach US $120 billion in 2020.

According to the data, the value of Chinese medicine market will reach US $120 billion in 2020, which is likely to surpass that of the United States as the world's largest pharmaceutical consumer. Strong medical market value, coupled with the deepening of new medical reform and the strengthening of national macro policy on the control of the field of medical circulation, a new tide of logistics construction will come back. And the improvement of medical security level, the logistics of medical products also put forward higher requirements, especially the need for cold storage of cold storage products fast development, medical cold chain logistics has also entered a rapid growth period.
 
The rise of medical logistics construction, cold chain or will become a big winner.
 
China is the third largest pharmaceutical market in the world. The continuous and stable economic development and the improvement of people's demand for medical consumption have made the scale of the whole pharmaceutical market gradually expanded. The demand for drugs in the market, especially the need for cold storage, is increasing year by year. The related data showed that the sales amount of vaccine products, injection needle, tincture, oral medicine, foreign drugs, blood products and other pharmaceutical cold collections accounted for about 10% of the total sales of Chinese pharmaceutical circulation enterprises. To a certain extent, this also promotes the transformation of pharmaceutical logistics, especially the cold chain logistics of medicine.
 
In recent years, China's biopharmaceutical industry has developed rapidly. In the international stage, Chinese pharmaceutical enterprises are often seen in the international stage. Foreign media also affirm the progress of Chinese biopharmaceutical technology. Some experts say that the future of biological and biochemical pharmaceutical industry will remain stable, and the development of biopharmaceutical technology will also become a powerful driving force to promote the continuous expansion of the pharmaceutical cold chain logistics market.
The problem of drug safety not only affects the hearts of patients and their families, but also attracts the attention of the state. In the related cases, the negative events caused by the improper logistics process of vaccines, temperature and humidity sensitive drugs have been exposed repeatedly, and the cold chain logistics of medicine has caused the attention of the government departments and the people.

In addition to the above three angles, the deepening of the new medical reform and the support of relevant medical policies have also played an important role in the medical cold chain logistics in different degrees.
 
Pharmaceutical cold chain logistics market prospects are good, industry problems remain to be solved.
 
Although the market prospect of pharmaceutical cold chain logistics in China is promising, the current situation has to attract the attention of industry and enterprises.
 
The first is the question of "quantity" and "quality".
In terms of "quantity", there is still a phenomenon of unbalanced regional development in the cold chain logistics of our country, the stock of resources is less, the cold storage still faces the irrational structure of resources, and there are many situations in the East, the East and the west, and the cold storage of the freezer.
 
In terms of quality, cold chain equipment is not directly proportional to demand. More importantly, the cold chain standard of the GSP2012 version is the advanced standard from the original backward situation to the world. Most of the cold chain equipment in our country is not ready to be fully prepared. It is difficult to transition to the world standard at a sudden.
 
And then it's the problem of information. Medical products need to be controlled in the process of production, storage and transportation. However, limited by technical conditions, there is no complete networking of medical products in various circulation nodes. It is difficult to realize information sharing, and can not monitor the temperature of the products in real time. Most of the logistics companies are still using the method of artificial confirmation of temperature, the simple cold chain management, can not achieve the continuity, accuracy and non modification of temperature control data.
 
The second is the problem of professional talents. Medicine cold chain logistics has a high demand for talents, not only need to know the knowledge of logistics, but also need medical knowledge. Although the talent gap in the pharmaceutical logistics industry is large, but at present, most colleges and universities do not specializes in medical logistics specialties. The logistics or medical personnel recruited by enterprises need to be trained in the follow-up and need to consume a lot of cost.
Finally, it is the problem of industry competition. According to the analysis, at present, there are mainly two kinds of pharmaceutical cold chain logistics, one is traditional pharmaceutical enterprises, the other is social logistics enterprises. Traditional pharmaceutical enterprises mainly focus on warehousing management, and the entry of social logistics aggravates the competition of the industry. In addition, the State Council's approval measures for the third party drug logistics will further push the industry competition to a climax.

To solve industry problems, enterprises and governments need to work together
 
In drug transportation, the biggest profit is the cold chain transportation, which has become the market heights for many pharmaceutical logistics enterprises. But the medical cold chain logistics is not a field that any enterprise can involve. It not only has high requirements for the storage management of drugs, but also selects the cold chain equipment and distribution ability.
 
Enterprises should also strengthen the construction of the talent team, enterprises can cooperate with the school, after all, the school has a rich talent resources, so not only save cost, but also professional training of relevant personnel. In addition, qualified enterprises can also send outstanding employees abroad to study abroad. Advanced foreign technology and experience can provide more practical and effective help for employees.
 
The government should actively introduce relevant laws and regulations and policies to promote the development of medical cold chain, and guide the development of medical cold chain logistics to the direction of scale, centralization, socialization, standardization, information and so on, so as to play a binding and normative role to the whole industry. Experts also suggest that the government can build a medical traceability system at the public welfare level to escort the development of pharmaceutical cold chain.
 
Source: hundreds of millions of European, CCCA editing and editing

Sign In